Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.
paper
Cited
Public
Unavailable
- Authors
- Zhou, Xin; Zhuo, Xiaoliang; Xie, Fang; Kluetzman, Kerri; Shu, Yue-Zhong; Humphreys, W Griffith; Ding, Xinxin
- Year
- 2010
- Journal
- The Journal of pharmacology and experimental therapeutics
- PMID
- 19923441
- DOI
- 10.1124/jpet.109.162610
- PMCID
- PMC2812111
CYP2A5, a mouse cytochrome P450 monooxygenase that shows high similarities to human CYP2A6 and CYP2A13 in protein sequence and substrate specificity, is expressed in multiple tissues, including the liver, kidney, lung, and nasal mucosa. Heterologously expressed CYP2A5 is active in the metabolism of both endogenous substrates, such as testosterone, and xenobiotic compounds, such as nicotine and cotinine. To determine the biological and pharmacological functions of CYP2A5 in vivo, we have generated a Cyp2a5-null mouse. Homozygous Cyp2a5-null mice are viable and fertile; they show no evidence of embryonic lethality or developmental deficits; and they have normal circulating levels of testosterone and progesterone. The Cyp2a5-null mouse and wild-type mouse were then used for determination of the roles of CYP2A5 in the metabolism of nicotine and its major circulating metabolite, cotinine. The results indicated that the Cyp2a5-null mouse has lower hepatic nicotine 5'-hydroxylation activity in vitro, and slower systemic clearance of both nicotine and cotinine in vivo. For both compounds, a substantially longer plasma half-life and a greater area under the concentration-time curve were observed for the Cyp2a5-null mice, compared with wild-type mice. Further pharmacokinetics analysis confirmed that the brain levels of nicotine and cotinine are also influenced by the Cyp2a5 deletion. These findings provide direct evidence that CYP2A5 is the major nicotine and cotinine oxidase in mouse liver. The Cyp2a5-null mouse will be valuable for in vivo studies on the role of CYP2A5 in drug metabolism and chemical toxicity, and for future production of CYP2A6- and CYP2A13-humanized mouse models.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Inhibition of CYP2A6-mediated nicotine metabolism: A potential strategy for smoking cessation therapy. | Olawale ME et al. | β | 2026 | β |
| Chronic Exposure to E-Cigarettes Elevates CYP2A5 Activity, Protein Expression, and Cotinine-Induced Production of Reactive Oxygen Species in Mice. | Kanamori K et al. | β | 2024 | β |
| Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease. | Ruan S et al. | β | 2023 | β |
| Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases. | Echeverria V et al. | β | 2023 | β |
| Assessing cytochrome P450 function using genetically engineered mouse models. | Hannon SL et al. | β | 2022 | β |
| Genetic differences in nicotine sensitivity and metabolism in C57BL/6J and NOD/ShiLtJ mouse strains. | Seemiller LR et al. | β | 2022 | β |
| Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo. | Kanamori K et al. | β | 2022 | β |
| p53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl<sub>4</sub>. | Humpton TJ et al. | β | 2022 | β |
| Early-life nicotine or cotinine exposure produces long-lasting sleep alterations and downregulation of hippocampal corticosteroid receptors in adult mice. | Bastianini S et al. | β | 2021 | β |
| Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of Ξ±7 nicotinic acetylcholine receptors by kynurenic acid. | Mori Y et al. | β | 2021 | β |
| PPARΞ± agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase. | Chen X et al. | β | 2021 | β |
| Chronic electronic cigarette use elicits molecular changes related to pulmonary pathogenesis. | Marshall K et al. | β | 2020 | β |
| Postnatal Smoke Exposure Further Increases the Hepatic Nicotine Metabolism in Prenatally Smoke Exposed Male Offspring and Is Linked with Aberrant <i>Cyp2a5</i> Methylation. | Lkhagvadorj K et al. | β | 2020 | β |
| Prenatal smoke exposure induces persistent <i>Cyp2a5</i> methylation and increases nicotine metabolism in the liver of neonatal and adult male offspring. | Lkhagvadorj K et al. | β | 2020 | β |
| Reduced Chronic Toxicity and Carcinogenicity in A/J Mice in Response to Life-Time Exposure to Aerosol From a Heated Tobacco Product Compared With Cigarette Smoke. | Wong ET et al. | β | 2020 | β |
| The Impact of Sex on Changes in Plasma Corticosterone and Cotinine Levels Induced by Nicotine in C57BL/6J Mice. | Nguyen K et al. | β | 2020 | β |
| A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers. | Shao XM et al. | β | 2019 | β |
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | Wang K et al. | β | 2019 | β |
| Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it. | Verma H et al. | β | 2019 | β |
| Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice. | Engle ML et al. | β | 2019 | β |
| Induction via Functional Protein Stabilization of Hepatic Cytochromes P450 upon gp78/Autocrine Motility Factor Receptor (AMFR) Ubiquitin E3-Ligase Genetic Ablation in Mice: Therapeutic and Toxicological Relevance. | Kwon D et al. | β | 2019 | β |
| Nicotine inhibits rapamycin-induced pain through activating mTORC1/S6K/IRS-1-related feedback inhibition loop. | Li S et al. | β | 2019 | β |
| Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice. | Chen X et al. | β | 2019 | β |
| A CYP2B6-humanized mouse model and its potential applications. | Li L et al. | β | 2018 | β |
| Cytochrome P450s and Alcoholic Liver Disease. | Lu Y et al. | β | 2018 | β |
| Drug metabolizing enzymes and their inhibitors' role in cancer resistance. | Pathania S et al. | β | 2018 | β |
| Identification of 5-hydroxymethylfurfural in cigarette smoke extract as a new substrate metabolically activated by human cytochrome P450 2A13. | Ji M et al. | β | 2018 | β |
| Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. | Chen X et al. | β | 2018 | β |
| Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARΞ±-FGF21 axis. | Chen X et al. | β | 2017 | β |
| Alcoholic Liver Disease: from CYP2E1 to CYP2A5. | Leung TM et al. | β | 2017 | β |
| Enduring effects of perinatal nicotine exposure on murine sleep in adulthood. | Borniger JC et al. | β | 2017 | β |
| Omega-3 Polyunsaturated Fatty Acids Protect Against Cigarette Smoke-Induced Oxidative Stress and Vascular Dysfunction. | Wiest EF et al. | β | 2017 | β |
| Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species. | Lu Y et al. | β | 2016 | β |
| Effects of cigarette smoke, cessation and switching to a candidate modified risk tobacco product on the liver in Apoe -/- mice--a systems toxicology analysis. | Lo Sasso G et al. | β | 2016 | β |
| Effects of Fatty Acids on CYP2A5 and Nrf2 Expression in Mouse Primary Hepatocytes. | Cui Y et al. | β | 2016 | β |
| The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. | Hong F et al. | β | 2016 | β |
| Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice. | Hong F et al. | β | 2015 | β |
| Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo. | Liu Z et al. | β | 2015 | β |
| Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A Review. | Sanner T et al. | β | 2015 | β |
| Relative Contributions of CYP1A2 and CYP2E1 to the Bioactivation and Clearance of 4-Aminobiphenyl in Adult Mice. | Wang S et al. | β | 2015 | β |
| Abstracts of the10th International ISSX meeting, September 29βOctober 3, 2013, Toronto, Ontario, Canada. | β | β | 2014 | β |
| Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene. | Hu J et al. | β | 2014 | β |
| Generation and characterization of a novel CYP2A13--transgenic mouse model. | Jia K et al. | β | 2014 | β |
| Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse. | Li L et al. | β | 2014 | β |
| Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model. | Megaraj V et al. | β | 2014 | β |
| Smilax China root extract detoxifies nicotine by reducing reactive oxygen species and inducing CYP2A6. | Kim KM et al. | β | 2014 | β |
| Toxicity of gutkha, a smokeless tobacco product gone global: is there more to the toxicity than nicotine? | Willis DN et al. | β | 2014 | β |
| Direct quantitative analysis of nicotine alkaloids from biofluid samples using paper spray mass spectrometry. | Wang H et al. | β | 2013 | β |
| Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease. | Li R et al. | β | 2013 | β |
| Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model. | Wei Y et al. | β | 2013 | β |
| Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse. | Li L et al. | β | 2013 | β |
| Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model. | Wu H et al. | β | 2013 | β |
| An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes. | Ande A et al. | β | 2012 | β |
| Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway. | Lu Y et al. | β | 2012 | β |
| Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model. | Wei Y et al. | β | 2012 | β |
| Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse models. | Zhou X et al. | β | 2012 | β |
| Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. | Zhou X et al. | β | 2012 | β |
| Toxicity of nicotine by repeated intratracheal instillation to f344 rats. | Yokohira M et al. | β | 2012 | β |
| A novel defensive mechanism against acetaminophen toxicity in the mouse lateral nasal gland: role of CYP2A5-mediated regulation of testosterone homeostasis and salivary androgen-binding protein expression. | Zhou X et al. | β | 2011 | β |
| Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models. | Jiang XL et al. | β | 2011 | β |
| Ethanol induction of CYP2A5: permissive role for CYP2E1. | Lu Y et al. | β | 2011 | β |
| Generation and characterization of a Cyp2f2-null mouse and studies on the role of CYP2F2 in naphthalene-induced toxicity in the lung and nasal olfactory mucosa. | Li L et al. | β | 2011 | β |
| Humanized transgenic mouse models for drug metabolism and pharmacokinetic research. | Shen HW et al. | β | 2011 | β |
| The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5. | Xie F et al. | β | 2011 | β |
| Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues. | Wei Y et al. | β | 2010 | β |
| Mechanisms of olfactory toxicity of the herbicide 2,6-dichlorobenzonitrile: essential roles of CYP2A5 and target-tissue metabolic activation. | Xie F et al. | β | 2010 | β |